Affiliations 

  • 1 Department of Biosciences, Faculty of Science, Universiti Teknologi Malaysia, Johor Bahru, Johor, Malaysia
  • 2 Faculty of Medicine, King Fahad Medical City, Riyadh, Kingdom of Saudi Arabia
  • 3 Department of Biochemistry, Science College, King Saud University, Riyadh, Kingdom of Saudi Arabia
  • 4 Department of Biotechnology, Kulliyyah of Science, International Islamic University Malaysia, 25200, Bandar Indera Mahkota Kuantan, Pahang, Malaysia
  • 5 Central Laboratory, Center Female Center for Scientific and Medical Studies, King Saud University, Riyadh, Kingdom of Saudi Arabia
Biomedicine (Taipei), 2022;12(3):12-19.
PMID: 36381187 DOI: 10.37796/2211-8039.1355

Abstract

Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common enzyme deficiency disorder affecting over 400 million individuals worldwide. G6PD protects red blood cells (RBC) from the harmful effects of oxidative substances. There are more than 400 G6PD mutations, of which 186 variants have shown to be linked to G6PD deficiency by decreasing the activity or stability of the enzyme. Different variants manifest different clinical phenotypes which complicate comprehending the mechanism of the disease. In order to carry out computational approaches to elucidate the structural changes of different G6PD variants that are common to the Asian population, a complete G6PD monomer-ligand complex was constructed using AutoDock 4.2, and the molecular dynamics simulation package GROMACS 4.6.7 was used to study the protein dynamics. The G410D and V291M variants were chosen to represent classes I and II respectively and were created by in silico site-directed mutagenesis. Results from the Root mean square deviation (RMSD), Root mean square fluctuation (RMSF) and Radius of gyration (Rg) analyses provided insights on the structure - function relationship for the variants. G410D indicated impaired dimerization and structural NADP binding while the impaired catalytic activity for V291M was indicated by a conformational change at its mutation site.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.